Live feed20:39:16·285dINSIDERFilingvia QuantisnowChief Development Officer Yale Catriona sold $28,350 worth of shares (659 units at $43.02), decreasing direct ownership by 0.72% to 90,829 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.AKRO· Akero Therapeutics Inc.Health CareOriginal source